Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation

Zhiyong Liu, Weibin Shi, Xiaohui Ji, Chuanxi Sun, Webster S.S. Jee, Yalei Wu, Zhengkuan Mao, Tim R. Nagy, Qingnan Li, Xu Cao

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Bone morphogenetic proteins (BMPs) induce osteoblast differentiation and bone formation. Smads, a group of functionally and structurally related intracellular effectors, mediate signaling initiated by BMPs and regulate cell definite commitment. Previously, we showed that Smad1 activates osteopontin and osteoprotegerin gene expression by dislodging Hoxc-8 from its DNA binding sites. A domain of Smad1, termed Smad1C, was characterized as interacting with Hoxc-8 and then crippling its DNA-binding ability. Ectopic expression of Smad1C is able to bypass BMP signaling in the induction of osteoblast differentiation and bone formation in vitro. To test the function of Smad1C on osteogenesis in vivo, we generated transgenic mice in which Smad1C expression was induced with doxycycline and localized in bone by using a tetracycline-inducible expression system (Tet-on) modified with a bone-specific gene promoter, type I collagen α1. The mice expressing Smad1C showed increased skeletal bone mineral density compared with their littermates. Bone histomorphometric analysis of mouse tibiae showed that Smad1C significantly increases trabecular bone area and length of trabecular surface covered with osteoid and up-regulates bone marker gene (OPN, Cbfa1, Col I α1, BSP, ALP) expression in vivo. Moreover, stromal cells isolated from mice expressing Smad1C displayed a higher potential for differentiating into osteoblasts than the other mice. These results indicate that Smad1C mimics BMPs in the induction of osteogenesis in vivo. Most important, using a high throughput screening assay based on mimicking Smad1C's displacement of Hoxc-8 binding to DNA, we identified chemical entities that exhibit bone anabolic activity in cell and bone organ cultures, suggesting the possibility that the compounds may be used as bone anabolic agents to treat bone pathologies.

Original languageEnglish (US)
Pages (from-to)11313-11319
Number of pages7
JournalJournal of Biological Chemistry
Volume279
Issue number12
DOIs
StatePublished - Mar 19 2004

Fingerprint

Osteogenesis
Bone
Bone and Bones
Bone Morphogenetic Proteins
Molecules
Osteoblasts
DNA
High-Throughput Screening Assays
Osteoprotegerin
Anabolic Agents
Osteopontin
Doxycycline
Organ Culture Techniques
Stromal Cells
Collagen Type I
Genes
Tetracycline
Tibia
Bone Density
Transgenic Mice

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Liu, Zhiyong ; Shi, Weibin ; Ji, Xiaohui ; Sun, Chuanxi ; Jee, Webster S.S. ; Wu, Yalei ; Mao, Zhengkuan ; Nagy, Tim R. ; Li, Qingnan ; Cao, Xu. / Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 12. pp. 11313-11319.
@article{3df93b52990a43f59b068ec1f6a7d152,
title = "Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation",
abstract = "Bone morphogenetic proteins (BMPs) induce osteoblast differentiation and bone formation. Smads, a group of functionally and structurally related intracellular effectors, mediate signaling initiated by BMPs and regulate cell definite commitment. Previously, we showed that Smad1 activates osteopontin and osteoprotegerin gene expression by dislodging Hoxc-8 from its DNA binding sites. A domain of Smad1, termed Smad1C, was characterized as interacting with Hoxc-8 and then crippling its DNA-binding ability. Ectopic expression of Smad1C is able to bypass BMP signaling in the induction of osteoblast differentiation and bone formation in vitro. To test the function of Smad1C on osteogenesis in vivo, we generated transgenic mice in which Smad1C expression was induced with doxycycline and localized in bone by using a tetracycline-inducible expression system (Tet-on) modified with a bone-specific gene promoter, type I collagen α1. The mice expressing Smad1C showed increased skeletal bone mineral density compared with their littermates. Bone histomorphometric analysis of mouse tibiae showed that Smad1C significantly increases trabecular bone area and length of trabecular surface covered with osteoid and up-regulates bone marker gene (OPN, Cbfa1, Col I α1, BSP, ALP) expression in vivo. Moreover, stromal cells isolated from mice expressing Smad1C displayed a higher potential for differentiating into osteoblasts than the other mice. These results indicate that Smad1C mimics BMPs in the induction of osteogenesis in vivo. Most important, using a high throughput screening assay based on mimicking Smad1C's displacement of Hoxc-8 binding to DNA, we identified chemical entities that exhibit bone anabolic activity in cell and bone organ cultures, suggesting the possibility that the compounds may be used as bone anabolic agents to treat bone pathologies.",
author = "Zhiyong Liu and Weibin Shi and Xiaohui Ji and Chuanxi Sun and Jee, {Webster S.S.} and Yalei Wu and Zhengkuan Mao and Nagy, {Tim R.} and Qingnan Li and Xu Cao",
year = "2004",
month = "3",
day = "19",
doi = "10.1074/jbc.M312731200",
language = "English (US)",
volume = "279",
pages = "11313--11319",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

Liu, Z, Shi, W, Ji, X, Sun, C, Jee, WSS, Wu, Y, Mao, Z, Nagy, TR, Li, Q & Cao, X 2004, 'Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation', Journal of Biological Chemistry, vol. 279, no. 12, pp. 11313-11319. https://doi.org/10.1074/jbc.M312731200

Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation. / Liu, Zhiyong; Shi, Weibin; Ji, Xiaohui; Sun, Chuanxi; Jee, Webster S.S.; Wu, Yalei; Mao, Zhengkuan; Nagy, Tim R.; Li, Qingnan; Cao, Xu.

In: Journal of Biological Chemistry, Vol. 279, No. 12, 19.03.2004, p. 11313-11319.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation

AU - Liu, Zhiyong

AU - Shi, Weibin

AU - Ji, Xiaohui

AU - Sun, Chuanxi

AU - Jee, Webster S.S.

AU - Wu, Yalei

AU - Mao, Zhengkuan

AU - Nagy, Tim R.

AU - Li, Qingnan

AU - Cao, Xu

PY - 2004/3/19

Y1 - 2004/3/19

N2 - Bone morphogenetic proteins (BMPs) induce osteoblast differentiation and bone formation. Smads, a group of functionally and structurally related intracellular effectors, mediate signaling initiated by BMPs and regulate cell definite commitment. Previously, we showed that Smad1 activates osteopontin and osteoprotegerin gene expression by dislodging Hoxc-8 from its DNA binding sites. A domain of Smad1, termed Smad1C, was characterized as interacting with Hoxc-8 and then crippling its DNA-binding ability. Ectopic expression of Smad1C is able to bypass BMP signaling in the induction of osteoblast differentiation and bone formation in vitro. To test the function of Smad1C on osteogenesis in vivo, we generated transgenic mice in which Smad1C expression was induced with doxycycline and localized in bone by using a tetracycline-inducible expression system (Tet-on) modified with a bone-specific gene promoter, type I collagen α1. The mice expressing Smad1C showed increased skeletal bone mineral density compared with their littermates. Bone histomorphometric analysis of mouse tibiae showed that Smad1C significantly increases trabecular bone area and length of trabecular surface covered with osteoid and up-regulates bone marker gene (OPN, Cbfa1, Col I α1, BSP, ALP) expression in vivo. Moreover, stromal cells isolated from mice expressing Smad1C displayed a higher potential for differentiating into osteoblasts than the other mice. These results indicate that Smad1C mimics BMPs in the induction of osteogenesis in vivo. Most important, using a high throughput screening assay based on mimicking Smad1C's displacement of Hoxc-8 binding to DNA, we identified chemical entities that exhibit bone anabolic activity in cell and bone organ cultures, suggesting the possibility that the compounds may be used as bone anabolic agents to treat bone pathologies.

AB - Bone morphogenetic proteins (BMPs) induce osteoblast differentiation and bone formation. Smads, a group of functionally and structurally related intracellular effectors, mediate signaling initiated by BMPs and regulate cell definite commitment. Previously, we showed that Smad1 activates osteopontin and osteoprotegerin gene expression by dislodging Hoxc-8 from its DNA binding sites. A domain of Smad1, termed Smad1C, was characterized as interacting with Hoxc-8 and then crippling its DNA-binding ability. Ectopic expression of Smad1C is able to bypass BMP signaling in the induction of osteoblast differentiation and bone formation in vitro. To test the function of Smad1C on osteogenesis in vivo, we generated transgenic mice in which Smad1C expression was induced with doxycycline and localized in bone by using a tetracycline-inducible expression system (Tet-on) modified with a bone-specific gene promoter, type I collagen α1. The mice expressing Smad1C showed increased skeletal bone mineral density compared with their littermates. Bone histomorphometric analysis of mouse tibiae showed that Smad1C significantly increases trabecular bone area and length of trabecular surface covered with osteoid and up-regulates bone marker gene (OPN, Cbfa1, Col I α1, BSP, ALP) expression in vivo. Moreover, stromal cells isolated from mice expressing Smad1C displayed a higher potential for differentiating into osteoblasts than the other mice. These results indicate that Smad1C mimics BMPs in the induction of osteogenesis in vivo. Most important, using a high throughput screening assay based on mimicking Smad1C's displacement of Hoxc-8 binding to DNA, we identified chemical entities that exhibit bone anabolic activity in cell and bone organ cultures, suggesting the possibility that the compounds may be used as bone anabolic agents to treat bone pathologies.

UR - http://www.scopus.com/inward/record.url?scp=12144286258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144286258&partnerID=8YFLogxK

U2 - 10.1074/jbc.M312731200

DO - 10.1074/jbc.M312731200

M3 - Article

C2 - 14672939

AN - SCOPUS:12144286258

VL - 279

SP - 11313

EP - 11319

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -